mortality/aging
• in LPS-treated mice
|
immune system
• in LPS-treated mice
|
• in LPS-treated mice
|
• LPS-treated mice exhibit a strong decrease in serum TNFalpha levels compared with similarly treated wild-type mice
• mice treated with collagen to induce arthritis exhibit decreased serum TNFalpha levels compared with similarly treated wild-type mice
|
• in thioglycollate-elicited peritoneal macrophages from LPS-treated mice
|
• mice treated with collagen to induce arthritis exhibit delayed onset, lower incidence, and decreased severity of arthritis with reduced swelling of joints, bone destruction, and serum TNF-alpha compared with similarly treated wild-type mice
|
• with reduced mortality and circulating levels of IL6, IL1b, and TNF-alpha
|
• in LPS-treated mice
|
homeostasis/metabolism
• in LPS-treated mice
|
• in LPS-treated mice
|
• LPS-treated mice exhibit a strong decrease in serum TNFalpha levels compared with similarly treated wild-type mice
• mice treated with collagen to induce arthritis exhibit decreased serum TNFalpha levels compared with similarly treated wild-type mice
|
skeleton
• mice treated with collagen to induce arthritis exhibit delayed onset, lower incidence, and decreased severity of arthritis with reduced swelling of joints, bone destruction, and serum TNF-alpha compared with similarly treated wild-type mice
|